Commission supports crucial research on convalescent plasma to treat COVID-19
An important new EU-funded research project, SUPPORT-E, will support and coordinate efforts to determine if COVID-19 convalescent plasma transfusion – using plasma from patients who recovered from the disease - is an effective and safe treatment. The Commission announced today that it will support the project with €4 million.
Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said:
Using plasma from patients that have recovered from Covid-19 and developed an immune response is a very promising avenue for treating the disease, but we need more evidence of efficacy and safety. The Commission is playing an important role by supporting international efforts to provide the evidence to assess the potential of this therapy and to ensure it has no serious adverse effects.
The European Commission is committed to personal data protection. Any personal data is processed in line with the Regulation (EU) 2018/1725. Please read the privacy statement.
Stay up to date and subscribe to our newsletter | To unsubscribe or change your profile and selections please visit our web site.
